| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Year | PBM | Parent | Revenue ($ bill) | Gross Profit | SG&A | Operating Expenses | Net Income | Operating Income | Gross Profit/Revenue | Operating Income/Revenue | Notes | Source | |||||||||||||
2 | 2000 | Express Scripts | 6.101 | 0.5389 | 0.338 | 0.156 | 0.2002 | 8.8% | 3.3% | Includes a non-cash write-off of $165,207 ($103,089 net of tax) of our investment in PlanetRx.com, Inc. | https://www.sec.gov/Archives/edgar/data/885721/000088572105000057/form10k-2004.htm | |||||||||||||||
3 | 2001 | Express Scripts | 8.588 | 0.5958 | 0.358 | 0.1247 | 0.2372 | 6.9% | 2.8% | https://www.sec.gov/Archives/edgar/data/885721/000088572105000057/form10k-2004.htm | ||||||||||||||||
4 | 2002 | Express Scripts | 12.27 | 0.8234 | 0.451 | 0.202 | 0.3717 | 6.7% | 3.0% | https://www.sec.gov/Archives/edgar/data/885721/000088572105000057/form10k-2004.htm | ||||||||||||||||
5 | 2003 | Express Scripts | 13.294 | 0.8663 | 0.417 | 0.249 | 0.4491 | 6.5% | 3.4% | https://www.sec.gov/Archives/edgar/data/885721/000088572105000057/form10k-2004.htm | ||||||||||||||||
6 | 2004 | Express Scripts | 15.115 | 0.9442 | 0.451 | 0.278 | 0.4929 | 6.2% | 3.3% | Includes the acquisition of Curascript effective January 30, 2004. | https://www.sec.gov/Archives/edgar/data/885721/000088572105000057/form10k-2004.htm | |||||||||||||||
7 | 2005 | Express Scripts | 21.879 | 1.185 | 0.543 | 0.4 | 0.6423 | 5.4% | 2.9% | https://www.sec.gov/Archives/edgar/data/885721/000095012310016370/c54821e10vk.htm | ||||||||||||||||
8 | 2006 | Express Scripts | 21.562 | 1.468 | 0.643 | 0.474 | 0.8258 | 6.8% | 3.8% | https://www.sec.gov/Archives/edgar/data/885721/000095012310016370/c54821e10vk.htm | ||||||||||||||||
9 | 2007 | Express Scripts | 21.824 | 1.758 | 0.698 | 0.568 | 1.056 | 8.1% | 4.8% | https://www.sec.gov/Archives/edgar/data/885721/000095012310016370/c54821e10vk.htm | ||||||||||||||||
10 | 2008 | Express Scripts | 21.978 | 2.041 | 0.76 | 0.776 | 1.274 | 9.3% | 5.8% | https://www.sec.gov/Archives/edgar/data/885721/000095012310016370/c54821e10vk.htm | ||||||||||||||||
11 | 2009 | Express Scripts | 24.748 | 2.43 | 0.932 | 0.827 | 1.497 | 9.8% | 6.0% | https://www.sec.gov/Archives/edgar/data/885721/000095012310016370/c54821e10vk.htm | ||||||||||||||||
12 | 2010 | Express Scripts | 44.973 | 2.958 | 0.8873 | 1.181 | 2.071 | 6.6% | 4.6% | Dec 2009 acquisition of WellPoint's NextRx (later Anthem), 10 year contract with Anthem, DoD contract | https://www.sec.gov/Archives/edgar/data/885721/000119312512072758/d262132d10k.htm | |||||||||||||||
13 | 2011 | Express Scripts | 46.128 | 3.209 | 0.8982 | 1.275 | 2.314 | 7.0% | 5.0% | https://www.sec.gov/Archives/edgar/data/885721/000119312512072758/d262132d10k.htm | ||||||||||||||||
14 | 2012 | Express Scripts | 93.714 | 7.312 | 4.58 | 1.33 | 2.793 | 7.8% | 3.0% | https://www.sec.gov/Archives/edgar/data/1532063/000153206316000017/esrx-12312015x10k.htm#sC9ECE1DB3F12A75EC1ECE0F0181CB436 | ||||||||||||||||
15 | 2013 | Express Scripts | 104.098 | 8.132 | 4.518 | 1.872 | 3.551 | 7.8% | 3.4% | https://www.sec.gov/Archives/edgar/data/1532063/000153206316000017/esrx-12312015x10k.htm#sC9ECE1DB3F12A75EC1ECE0F0181CB436 | ||||||||||||||||
16 | 2014 | Express Scripts | 100.887 | 7.925 | 4.32 | 2.035 | 3.602 | 7.9% | 3.6% | https://www.sec.gov/Archives/edgar/data/1532063/000153206316000017/esrx-12312015x10k.htm#sC9ECE1DB3F12A75EC1ECE0F0181CB436 | ||||||||||||||||
17 | 2015 | Express Scripts | 101.751 | 8.401 | 4.062 | 2.499 | 4.339 | 8.3% | 4.3% | https://www.sec.gov/Archives/edgar/data/1532063/000153206316000017/esrx-12312015x10k.htm#sC9ECE1DB3F12A75EC1ECE0F0181CB436 | ||||||||||||||||
18 | 2016 | Express Scripts | 100.287 | 8.62 | 3.5327 | 3.427 | 5.087 | 8.6% | 5.1% | Includes the acquisitions of myMatrixx Holdings, Inc. (“myMatrixx”) on May 15, 2017 and CareCore National Group, LLC and its affiliates d/b/a eviCore healthcare (“eviCore”) on December 15, 2017, and the sale of UBC on December 27, 2017. | https://www.sec.gov/Archives/edgar/data/1532063/000153206318000004/esrx-12312017x10k.htm#s292B544F205F5EE5B67E5937209B0EE0 | |||||||||||||||
19 | 2017 | Express Scripts | 100.064 | 8.762 | 3.2681 | 4.531 | 5.494 | 8.8% | 5.5% | https://www.sec.gov/Archives/edgar/data/1532063/000153206318000004/esrx-12312017x10k.htm#s292B544F205F5EE5B67E5937209B0EE0 | ||||||||||||||||
20 | 2018 | Express Scripts | Merger closed in Dec 2018 | https://www.sec.gov/ix?doc=/Archives/edgar/data/1739940/000173994020000006/ci-20191231.htm | ||||||||||||||||||||||
21 | 2019 | Express Scripts | Cigna | 109.794 | 8.908 | 5.092 | 8.1% | 4.6% | See "Health Services Segment" table; Cigna pharmacy: 5.479, 2.979 revenue in 2018 and 2017 | https://www.sec.gov/ix?doc=/Archives/edgar/data/1739940/000173994020000006/ci-20191231.htm | ||||||||||||||||
22 | 2000 | Medco | 20.14 | No other data reported by Merck | https://www.sec.gov/Archives/edgar/data/64978/000095013002001788/d10k405.txt | |||||||||||||||||||||
23 | 2001 | Medco | 26.368 | No other data reported by Merck | https://www.sec.gov/Archives/edgar/data/64978/000095013002001788/d10k405.txt | |||||||||||||||||||||
24 | 2002 | Medco | 32.958 | 1.301 | 0.5877 | 0.3616 | 0.6203 | 3.9% | 1.9% | https://www.sec.gov/Archives/edgar/data/1170650/000119312507037148/d10k.htm#toc40544_10 | ||||||||||||||||
25 | 2003 | Medco | 34.264 | 1.522 | 0.6864 | 0.4258 | 0.7287 | 4.4% | 2.1% | https://www.sec.gov/Archives/edgar/data/1170650/000119312507037148/d10k.htm#toc40544_10 | ||||||||||||||||
26 | 2004 | Medco | 35.351 | 1.722 | 0.6764 | 0.4816 | 0.8063 | 4.9% | 2.3% | https://www.sec.gov/Archives/edgar/data/1170650/000119312507037148/d10k.htm#toc40544_10 | ||||||||||||||||
27 | 2005 | Medco | 37.87 | 1.942 | 0.7576 | 0.602 | 0.9529 | 5.1% | 2.5% | https://www.sec.gov/Archives/edgar/data/1170650/000119312507037148/d10k.htm#toc40544_10 | ||||||||||||||||
28 | 2006 | Medco | 42.543 | 2.405 | 1.1092 | 0.6302 | 1.011 | 5.7% | 2.4% | https://www.sec.gov/Archives/edgar/data/1170650/000119312507037148/d10k.htm#toc40544_10 | ||||||||||||||||
29 | 2007 | Medco | 44.506 | 2.946 | 1.114 | 0.912 | 1.503 | 6.6% | 3.4% | https://www.sec.gov/Archives/edgar/data/1170650/000095012312002878/c25663e10vk.htm#C25663110 | ||||||||||||||||
30 | 2008 | Medco | 51.258 | 3.729 | 1.425 | 1.102 | 1.791 | 7.3% | 3.5% | https://www.sec.gov/Archives/edgar/data/1170650/000095012312002878/c25663e10vk.htm#C25663110 | ||||||||||||||||
31 | 2009 | Medco | 59.804 | 4.027 | 1.455 | 1.28 | 2.103 | 6.7% | 3.5% | https://www.sec.gov/Archives/edgar/data/1170650/000095012312002878/c25663e10vk.htm#C25663110 | ||||||||||||||||
32 | 2010 | Medco | 65.968 | 4.335 | 1.55 | 1.427 | 2.334 | 6.6% | 3.5% | https://www.sec.gov/Archives/edgar/data/1170650/000095012312002878/c25663e10vk.htm#C25663110 | ||||||||||||||||
33 | 2011 | Medco | 70.063 | 4.622 | 1.744 | 1.455 | 2.375 | 6.6% | 3.4% | Merged with Express Scripts | https://www.sec.gov/Archives/edgar/data/1170650/000095012312002878/c25663e10vk.htm#C25663110 | |||||||||||||||
34 | 2000 | CVS/Caremark | 4.43 | 0.352 | 0.1162 | 0.104 | 0.21 | 7.9% | 4.7% | https://www.sec.gov/Archives/edgar/data/1000736/000095014401003724/g67556e10-k.htm | ||||||||||||||||
35 | 2001 | CVS/Caremark | 5.614 | 0.445 | 0.1473 | 0.19 | 0.27 | 7.9% | 4.8% | https://www.sec.gov/Archives/edgar/data/1000736/000119312504036471/d10k.htm | ||||||||||||||||
36 | 2002 | CVS/Caremark | 6.805 | 0.578 | 0.1676 | 0.308 | 0.3806 | 8.5% | 5.6% | Deferred tax benefit included in income | https://www.sec.gov/Archives/edgar/data/1000736/000119312504036471/d10k.htm | |||||||||||||||
37 | 2003 | CVS/Caremark | 9.067 | 0.768 | 0.1923 | 0.291 | 0.527 | 8.5% | 5.8% | Merger w/ AdvancePCS (5.6 bill) | https://www.sec.gov/Archives/edgar/data/1000736/000119312504036471/d10k.htm | |||||||||||||||
38 | 2004 | CVS/Caremark | 25.801 | 1.609 | 0.431 | 0.6003 | 1.028 | 6.2% | 4.0% | Includes 4.6 bill copays; big jump post merger | https://www.sec.gov/Archives/edgar/data/1000736/000119312507040033/d10k.htm | |||||||||||||||
39 | 2005 | CVS/Caremark | 32.991 | 2.103 | 0.474 | 0.9324 | 1.469 | 6.4% | 4.5% | Includes 5.5 bill copays | https://www.sec.gov/Archives/edgar/data/1000736/000119312507040033/d10k.htm | |||||||||||||||
40 | 2006 | CVS/Caremark | 36.75 | 2.406 | 0.546 | 1.074 | 1.714 | 6.5% | 4.7% | Includes 5.8 bill copays | https://www.sec.gov/Archives/edgar/data/1000736/000119312507040033/d10k.htm | |||||||||||||||
41 | 2007 | CVS/Caremark | CVS | 34.938 | 2.997 | 0.752 | 2.245 | 8.6% | 6.4% | Deal closed in Mar 2007; total net income: 2.637; 4.6 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/dex13.htm | |||||||||||||||
42 | 2008 | CVS/Caremark | CVS | 43.769 | 3.559 | 0.795 | 2.755 | 8.1% | 6.3% | Total net income: 3.212; 6.3 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/dex13.htm | |||||||||||||||
43 | 2009 | CVS/Caremark | CVS | 51.065 | 3.835 | 0.969 | 2.866 | 7.5% | 5.6% | Total net income: 3.696; 6.9 bill copay; use operating profits in numerator | https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/dex13.htm | |||||||||||||||
44 | 2010 | CVS/Caremark | CVS | 47.145 | 3.315 | 0.954 | 2.361 | 7.0% | 5.0% | 6.6 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/a12-28799_1ex13.htm | |||||||||||||||
45 | 2011 | CVS/Caremark | CVS | 58.874 | 3.279 | 1.059 | 2.22 | 5.6% | 3.8% | 7.9 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/a12-28799_1ex13.htm | |||||||||||||||
46 | 2012 | CVS/Caremark | CVS | 73.444 | 3.808 | 1.129 | 2.679 | 5.2% | 3.6% | 8.4 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/a12-28799_1ex13.htm | |||||||||||||||
47 | 2013 | CVS/Caremark | CVS | 76.208 | 4.237 | 1.151 | 3.086 | 5.6% | 4.0% | 7.9 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/ex13portionsofannualreport.htm | |||||||||||||||
48 | 2014 | CVS/Caremark | CVS | 88.44 | 4.771 | 1.257 | 3.514 | 5.4% | 4.0% | 8.1 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/ex13portionsofannualreport.htm | |||||||||||||||
49 | 2015 | CVS/Caremark | CVS | 100.363 | 5.227 | 1.238 | 3.989 | 5.2% | 4.0% | Aug 2015: acquired Advance Care Scripts (Omnicare) for 9.6 bill; 8.9 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/ex13portionsofannualreport.htm | |||||||||||||||
50 | 2016 | CVS/Caremark | CVS | 119.965 | 5.837 | 1.267 | 4.57 | 4.9% | 3.8% | 10.5 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex131.htm | |||||||||||||||
51 | 2017 | CVS/Caremark | CVS | 130.822 | 5.992 | 1.335 | 4.657 | 4.6% | 3.6% | 10.8 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex131.htm | |||||||||||||||
52 | 2018 | CVS/Caremark | CVS | 134.736 | 6.216 | 1.517 | 4.699 | 4.6% | 3.5% | Nov 2018 merger w/ Aetna closed; 11.4 bill copay | https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex131.htm | |||||||||||||||
53 | 2019 | CVS/Caremark | CVS | 141.491 | 6.246 | 1.511 | 4.735 | 4.4% | 3.3% | https://www.sec.gov/ix?doc=/Archives/edgar/data/64803/000006480320000007/a2019form10-k.htm | ||||||||||||||||
54 | 2006 | Optum | UnitedHealth | 4.084 | 0.139 | 3.4% | https://www.sec.gov/Archives/edgar/data/731766/000119312508035391/d10k.htm | |||||||||||||||||||
55 | 2007 | Optum | UnitedHealth | 13.249 | 0.269 | 2.0% | "Formerly Ovations business" | https://www.sec.gov/Archives/edgar/data/731766/000119312508035391/d10k.htm | ||||||||||||||||||
56 | 2008 | Optum | UnitedHealth | 12.57 | 0.363 | 2.9% | Intersegment revenues dominate (10.96) | https://www.sec.gov/Archives/edgar/data/731766/000119312511030615/d10k.htm | ||||||||||||||||||
57 | 2009 | Optum | UnitedHealth | 14.45 | 0.689 | 4.8% | Intersegment revenues dominate (12.56) | https://www.sec.gov/Archives/edgar/data/731766/000119312511030615/d10k.htm | ||||||||||||||||||
58 | 2010 | Optum | UnitedHealth | 16.776 | 0.534 | 3.2% | Intersegment revenues dominate (14.47) | https://www.sec.gov/Archives/edgar/data/731766/000119312511030615/d10k.htm | ||||||||||||||||||
59 | 2011 | Optum | UnitedHealth | 19.278 | 0.457 | 2.4% | https://www.sec.gov/Archives/edgar/data/731766/000073176614000008/unh2013123110-k.htm | |||||||||||||||||||
60 | 2012 | Optum | UnitedHealth | 18.359 | 0.393 | 2.1% | 15.611 are intersegment | https://www.sec.gov/Archives/edgar/data/731766/000073176614000008/unh2013123110-k.htm | ||||||||||||||||||
61 | 2013 | Optum | UnitedHealth | 24.006 | 0.735 | 3.1% | 28 million people; 20.839 are intersegment | https://www.sec.gov/Archives/edgar/data/731766/000073176614000008/unh2013123110-k.htm | ||||||||||||||||||
62 | 2014 | Optum | UnitedHealth | 31.976 | 1.19 | 3.7% | 27.7 is intersegment | https://www.sec.gov/Archives/edgar/data/731766/000073176617000009/unh2016123110-k.htm | ||||||||||||||||||
63 | 2015 | Optum | UnitedHealth | 48.272 | 1.749 | 3.6% | 30.72 is intersegment | https://www.sec.gov/Archives/edgar/data/731766/000073176617000009/unh2016123110-k.htm | ||||||||||||||||||
64 | 2016 | Optum | UnitedHealth | 60.44 | 2.682 | 4.4% | 33.37 is intersegment | https://www.sec.gov/Archives/edgar/data/731766/000073176617000009/unh2016123110-k.htm | ||||||||||||||||||
65 | 2017 | Optum | UnitedHealth | 63.755 | 3.118 | 4.9% | 36.954 is intersegment | https://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176620000006/unh2019123110-k.htm | ||||||||||||||||||
66 | 2018 | Optum | UnitedHealth | 69.536 | 3.558 | 5.1% | 39.44 is intersegment | https://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176620000006/unh2019123110-k.htm | ||||||||||||||||||
67 | 2019 | Optum | UnitedHealth | 74.288 | 3.902 | 5.3% | 42.09 is intersegment | https://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176620000006/unh2019123110-k.htm | ||||||||||||||||||
68 | 2008 | Catamaran/SXC | 0.771 | 0.069 | 8.9% | Foreign and primarily Health IT before this (acquired NMHC in 2008); two segments: PBM and Healthcare IT; makes very little in Canada | https://www.sec.gov/Archives/edgar/data/1363851/000095012309004593/c48729e10vk.htm | |||||||||||||||||||
69 | 2009 | Catamaran/SXC | 1.335 | 0.138 | 10.3% | https://www.sec.gov/Archives/edgar/data/1363851/000136385112000010/sxci10k123111.htm | ||||||||||||||||||||
70 | 2010 | Catamaran/SXC | 1.841 | 0.1596 | 8.7% | https://www.sec.gov/Archives/edgar/data/1363851/000136385112000010/sxci10k123111.htm | ||||||||||||||||||||
71 | 2011 | Catamaran/SXC | 4.859 | 0.2565 | 5.3% | Multiple acquisitions: PTRX, MedfusionRx, HealthTran LLC | https://www.sec.gov/Archives/edgar/data/1363851/000136385112000010/sxci10k123111.htm | |||||||||||||||||||
72 | 2012 | Catamaran/SXC | 9.785 | 0.644 | 6.6% | Multiple acquisitions: PTRX, MedfusionRx, HealthTran LLC | ||||||||||||||||||||
73 | 2013 | Catamaran/SXC | 14.632 | 1.048 | 7.2% | Acquired Catalyst in 2012 | ||||||||||||||||||||
74 | 2014 | Catamaran/SXC | 21.429 | 1.274 | 5.9% | |||||||||||||||||||||
75 | 2000 | AdvancePCS | 1.604 | 0.075 | 0.039 | 0.0207 | 0.036 | 4.7% | 2.2% | |||||||||||||||||
76 | 2001 | AdvancePCS | 6.49 | 0.229 | 0.129 | 0.0216 | 0.089 | 3.5% | 1.4% | |||||||||||||||||
77 | 2002 | AdvancePCS | 12.174 | 0.451 | 0.189 | 0.1157 | 0.26 | 3.7% | 2.1% | |||||||||||||||||
78 | 2003 | AdvancePCS | 14.111 | 0.555 | 0.231 | 0.168 | 0.324 | 3.9% | 2.3% | Purchased by Caremark in the next year | ||||||||||||||||
79 | 2000 | Catalyst | HealthExtras | 0.0048 | -0.000104 | -2.2% | Two segments: supplemental health, PBM | https://www.sec.gov/Archives/edgar/data/1090403/000109040302000004/tenk123101.txt | ||||||||||||||||||
80 | 2001 | Catalyst | HealthExtras | 0.0468 | -0.000000386 | 0.0% | https://www.sec.gov/Archives/edgar/data/1090403/000109040302000004/tenk123101.txt | |||||||||||||||||||
81 | 2002 | Catalyst | HealthExtras | 0.1822 | 0.008371 | 4.6% | https://www.sec.gov/Archives/edgar/data/1090403/000119312504042399/d10k.htm | |||||||||||||||||||
82 | 2003 | Catalyst | HealthExtras | 0.331 | 0.01377 | 4.2% | Acquired PNCC in 2002 | https://www.sec.gov/Archives/edgar/data/1090403/000119312504042399/d10k.htm | ||||||||||||||||||
83 | 2004 | Catalyst | HealthExtras | 0.4752 | 0.03892 | 8.2% | https://www.sec.gov/Archives/edgar/data/1090403/000119312507041967/d10k.htm | |||||||||||||||||||
84 | 2005 | Catalyst | HealthExtras | 0.6509 | 0.05666 | 8.7% | https://www.sec.gov/Archives/edgar/data/1090403/000119312507041967/d10k.htm | |||||||||||||||||||
85 | 2006 | Catalyst | HealthExtras | 1.229 | 0.0799 | 6.5% | https://www.sec.gov/Archives/edgar/data/1090403/000119312507041967/d10k.htm | |||||||||||||||||||
86 | 2007 | Catalyst | HealthExtras | 1.8577 | 0.1105 | 0.05399 | 0.0393 | 0.0564 | 5.9% | 3.0% | Back to 1 reportable segment | https://www.sec.gov/Archives/edgar/data/1090403/000119312510040818/d10k.htm#toc91176_10 | ||||||||||||||
87 | 2008 | Catalyst | HealthExtras | 2.5433 | 0.1432 | 0.0678 | 0.05039 | 0.0754 | 5.6% | 3.0% | https://www.sec.gov/Archives/edgar/data/1090403/000119312510040818/d10k.htm#toc91176_10 | |||||||||||||||
88 | 2009 | Catalyst | HealthExtras | 2.8944 | 0.1858 | 0.081 | 0.06516 | 0.1047 | 6.4% | 3.6% | https://www.sec.gov/Archives/edgar/data/1090403/000119312510040818/d10k.htm#toc91176_10 | |||||||||||||||
89 | 2010 | Catalyst | HealthExtras | 3.764 | 0.2342 | 0.1017 | 0.0809 | 0.1325 | 6.2% | 3.5% | Acquisitions of FutureScripts, LLC and FutureScripts Secure LLC | https://www.sec.gov/Archives/edgar/data/1090403/000119312512077512/d226587d10k.htm#toc226587_10 | ||||||||||||||
90 | 2011 | Catalyst | HealthExtras | 5.329 | 0.3073 | 0.1936 | 0.06658 | 0.11422 | 5.8% | 2.1% | Acquired by Catamaran/SXC in 2012 | https://www.sec.gov/Archives/edgar/data/1090403/000119312512077512/d226587d10k.htm#toc226587_10 | ||||||||||||||
91 | 2000 | NextRx | WellPoint | https://www.sec.gov/Archives/edgar/data/1013220/000104746903010911/a2105055z10-k.htm | ||||||||||||||||||||||
92 | 2001 | NextRx | WellPoint | Specialty Segment Info (only partly PBM); 32.8 mill pharmacy members | https://www.sec.gov/Archives/edgar/data/1013220/000104746904007997/a2128273z10-k.htm | |||||||||||||||||||||
93 | 2002 | NextRx | WellPoint | Specialty Segment Info (only partly PBM); 35 mill | https://www.sec.gov/Archives/edgar/data/1013220/000104746904007997/a2128273z10-k.htm | |||||||||||||||||||||
94 | 2003 | NextRx | WellPoint | Specialty Segment Info (only partly PBM); 31.2 mill members | https://www.sec.gov/Archives/edgar/data/1013220/000104746904007997/a2128273z10-k.htm | |||||||||||||||||||||
95 | 2004 | NextRx | Anthem/WellPoint | Specialty Segment Info (only partly PBM) | ||||||||||||||||||||||
96 | 2005 | NextRx | Anthem/WellPoint | Specialty Segment Info (only partly PBM) | ||||||||||||||||||||||
97 | 2006 | NextRx | Anthem/WellPoint | Specialty Segment Info (only partly PBM) | ||||||||||||||||||||||
98 | 2007 | NextRx | Anthem/WellPoint | Specialty Segment Info (only partly PBM) | ||||||||||||||||||||||
99 | 2008 | NextRx | Anthem/WellPoint | Specialty Segment Info (only partly PBM) | ||||||||||||||||||||||
100 | 2009 | NextRx | Anthem/WellPoint | Specialty Segment Info (only partly PBM) |